Literature DB >> 31875876

Neuropsychological Correlates of Anosognosia for Objective Functional Difficulties in Older Adults on the Mild Cognitive Impairment Spectrum.

Kayla A Steward1, Tyler P Bull1, Richard Kennedy2, Michael Crowe1, Virginia G Wadley2.   

Abstract

OBJECTIVE: To examine the neuropsychological correlates of anosognosia for instrumental activities of daily living (IADLs) in older adults with mild cognitive impairment (MCI) and mild dementia.
METHOD: Participants (n = 103; age range = 54-88, 52% female) with MCI and mild dementia were recruited from neurology and geriatrics clinics for cross-sectional analysis. They completed neuropsychological tests along with subjective and performance-based assessments of six IADLs: financial management, driving, grocery shopping, nutrition evaluation, telephone use, and medication management. For each IADL, participants were classified as having anosognosia when there was objective difficulty but no subjective complaints.
RESULTS: Depending on functional domain, 13-39% of the sample had objective IADL difficulty, and of those, 65-93% lacked insight into these deficits. Binomial logistic regression models controlling for demographic variables revealed that measures of global cognition, executive function, visual attention, and verbal memory predicted classification of anosognosia, and these relationships varied across IADLs. In contrast, basic auditory attention, working memory, depressive symptoms, nor cognitive reserve were significantly related to anosognosia for any IADL.
CONCLUSION: Results support the Conscious Awareness Model, which theorizes that accurate metacognitive output is reliant on attentional, memory, and executive functioning systems. Findings from this study suggest that anosognosia for different IADLs may arise from breakdowns at varying points in this model, explaining both inter- and intra-patient variability in self-awareness of functional deficits.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  Mild cognitive impairment; anosognosia; dementia; instrumental activities of daily living; neuropsychology

Mesh:

Year:  2020        PMID: 31875876      PMCID: PMC7244883          DOI: 10.1093/arclin/acz065

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  52 in total

1.  Timed instrumental activities of daily living tasks: relationship to visual function in older adults.

Authors:  C Owsley; G McGwin; M E Sloane; B T Stalvey; J Wells
Journal:  Optom Vis Sci       Date:  2001-05       Impact factor: 1.973

2.  Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment.

Authors:  E Kalbe; E Salmon; D Perani; V Holthoff; S Sorbi; A Elsner; S Weisenbach; M Brand; O Lenz; J Kessler; S Luedecke; P Ortelli; K Herholz
Journal:  Dement Geriatr Cogn Disord       Date:  2005-03-30       Impact factor: 2.959

3.  Grey matter changes associated with deficit awareness in mild cognitive impairment: a voxel-based morphometry study.

Authors:  Andrew H Ford; Osvaldo P Almeida; Leon Flicker; Griselda J Garrido; Kathryn R Greenop; Jonathan K Foster; Christopher Etherton-Beer; Frank M van Bockxmeer; Nicola T Lautenschlager
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Memory complaint, memory performance, and psychiatric diagnosis: a community study.

Authors:  S S Bassett; M F Folstein
Journal:  J Geriatr Psychiatry Neurol       Date:  1993 Apr-Jun       Impact factor: 2.680

5.  Neural correlates of reduced awareness in instrumental activities of daily living in frontotemporal dementia.

Authors:  Martina Amanzio; Federico D'Agata; Sara Palermo; Elisa Rubino; Milena Zucca; Antonello Galati; Lorenzo Pinessi; Giancarlo Castellano; Innocenzo Rainero
Journal:  Exp Gerontol       Date:  2016-08-14       Impact factor: 4.032

6.  Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.

Authors:  Yukiko Kashiwa; Yurinosuke Kitabayashi; Jin Narumoto; Kaeko Nakamura; Hideki Ueda; Kenji Fukui
Journal:  Psychiatry Clin Neurosci       Date:  2005-12       Impact factor: 5.188

7.  Age and education corrected older adult normative data for a short form version of the Financial Capacity Instrument.

Authors:  Adam Gerstenecker; Amanda Eakin; Kristen Triebel; Roy Martin; Dana Swenson-Dravis; Ronald C Petersen; Daniel Marson
Journal:  Psychol Assess       Date:  2015-07-13

8.  Validity of informant reports about AD and MCI patients' memory.

Authors:  Rebecca E Ready; Brian R Ott; Janet Grace
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Jan-Mar       Impact factor: 2.703

9.  Performance on the CERAD Word List Memory task: a comparison of university-based and community-based groups.

Authors:  Ross Andel; Carol A McCleary; Gail A Murdock; Amy Fiske; Rand R Wilcox; Margaret Gatz
Journal:  Int J Geriatr Psychiatry       Date:  2003-08       Impact factor: 3.485

Review 10.  Anosognosia, autobiographical memory and self knowledge in Alzheimer's disease.

Authors:  Robin G Morris; Daniel C Mograbi
Journal:  Cortex       Date:  2012-10-05       Impact factor: 4.027

View more
  2 in total

1.  Difficulty Taking Medications: a Corollary to Dementia Risk.

Authors:  Pei Chen; Kenneth Covinsky
Journal:  J Gen Intern Med       Date:  2021-02-02       Impact factor: 5.128

2.  Cognitive Processing Speed Is Strongly Related to Driving Skills, Financial Abilities, and Other Instrumental Activities of Daily Living in Persons With Mild Cognitive Impairment and Mild Dementia.

Authors:  Virginia G Wadley; Tyler P Bull; Yue Zhang; Cheyanne Barba; R Nick Bryan; Michael Crowe; Lisa Desiderio; Georg Deutsch; Guray Erus; David S Geldmacher; Rodney Go; Caroline L Lassen-Greene; Olga A Mamaeva; Daniel C Marson; Marianne McLaughlin; Ilya M Nasrallah; Cynthia Owsley; Jesse Passler; Rodney T Perry; Giovanna Pilonieta; Kayla A Steward; Richard E Kennedy
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.053

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.